SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/17/2024 at 13:35, 4 days 5 hours ago

Sanofi et Teva annoncent des résultats prometteurs de phase 2b pour Duvakitug

Maladie De Crohn Rectocolite Hémorragique Duvakitug Résultats De La Phase 2b Partenariat Entre Sanofi Et Teva
BRIEF

published on 12/17/2024 at 13:35, 4 days 5 hours ago

Sanofi and Teva Announce Promising Phase 2b Results for Duvakitug

Ulcerative Colitis Crohn’s Disease Duvakitug Phase 2b Results Sanofi And Teva Partnership
PRESS RELEASE

published on 12/17/2024 at 13:30, 4 days 5 hours ago

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn
Les résultats positifs de phase IIb du duvakitug pour la colite ulcéreuse et la maladie de Crohn ouvrent la voie à un programme de développement de phase III par Sanofi et Teva

Maladie De Crohn Colite Ulcéreuse Duvakitug Phase IIb Sanofi Teva
PRESS RELEASE

published on 12/17/2024 at 13:30, 4 days 5 hours ago

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
Sanofi and Teva announce positive phase 2b results for duvakitug in ulcerative colitis and Crohn's disease, showing promising potential in IBD. Phase 3 development planned

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 12/17/2024 at 07:35, 4 days 11 hours ago

Sanofi Releases Q4 2024 Aide-mémoire for Financial Modelling

Financial Results Investors Sanofi Aide-mémoire Q4 2024
BRIEF

published on 12/17/2024 at 07:35, 4 days 11 hours ago

Sanofi publie son aide-mémoire pour le quatrième trimestre 2024 sur la modélisation financière

Résultats Financiers Investisseurs Sanofi Aide-mémoire 4e Trimestre 2024
PRESS RELEASE

published on 12/17/2024 at 07:30, 4 days 11 hours ago

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »
Mise en ligne du document "Q4 2024 Aide-mémoire" par Sanofi pour assister la communauté financière dans la modélisation des résultats trimestriels. Annonce des résultats le 30 janvier 2025

Résultats Trimestriels Sanofi Q4 2024 Communauté Financière Document En Ligne
PRESS RELEASE

published on 12/17/2024 at 07:30, 4 days 11 hours ago

Press Release: Availability of the Q4 2024 Aide-mémoire
Sanofi announces availability of Q4 2024 Aide-mémoire for financial modelling purposes. Document includes details on exclusivity losses and foreign currency impact. Results to be published on January 30, 2025

Sanofi Q4 2024 Financial Modelling Exclusivity Losses Foreign Currency Impact
BRIEF

published on 12/13/2024 at 07:05, 8 days 12 hours ago

FDA Grants Breakthrough Therapy Status to Tolebrutinib for nrSPMS

Sanofi Tolebrutinib HERCULES Study FDA Breakthrough NrSPMS
BRIEF

published on 12/13/2024 at 07:05, 8 days 12 hours ago

La FDA accorde le statut de traitement révolutionnaire au tolébrutinib pour le traitement de la SEP non rémittente

Sanofi Tolebrutinib Étude HERCULES NrSPMS Découverte De La FDA

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 58 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 58 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 23 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 28 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 58 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 37 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 43 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 10 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 10 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE